Merit Medical Systems (NASDAQ:MMSI) Chairman Fred Lampropoulos Sells 5,000 Shares

Merit Medical Systems, Inc. (NASDAQ:MMSI) Chairman Fred Lampropoulos sold 5,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 18th. The stock was sold at an average price of $84.83, for a total transaction of $424,150.00. Following the transaction, the chairman directly owned 1,074,955 shares in the company, valued at $91,188,432.65. This represents a 0.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Merit Medical Systems Trading Up 1.6%

Shares of MMSI stock opened at $85.04 on Friday. The stock has a market cap of $5.04 billion, a P/E ratio of 43.17, a price-to-earnings-growth ratio of 2.62 and a beta of 0.64. Merit Medical Systems, Inc. has a 1 year low of $78.12 and a 1 year high of $111.45. The company has a current ratio of 4.09, a quick ratio of 2.66 and a debt-to-equity ratio of 0.49. The stock has a 50 day simple moving average of $83.77 and a 200 day simple moving average of $88.61.

Merit Medical Systems (NASDAQ:MMSI) last announced its quarterly earnings data on Thursday, October 30th. The medical instruments supplier reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.82 by $0.10. The firm had revenue of $384.16 million during the quarter, compared to analysts’ expectations of $371.69 million. Merit Medical Systems had a return on equity of 15.07% and a net margin of 8.31%.The company’s quarterly revenue was up 13.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.86 EPS. Merit Medical Systems has set its FY 2025 guidance at 3.660-3.790 EPS. On average, research analysts predict that Merit Medical Systems, Inc. will post 3.37 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have commented on MMSI shares. Needham & Company LLC reissued a “buy” rating and issued a $108.00 target price on shares of Merit Medical Systems in a report on Friday, October 31st. Raymond James Financial reduced their price target on shares of Merit Medical Systems from $108.00 to $102.00 and set an “outperform” rating on the stock in a research report on Thursday, July 31st. Robert W. Baird set a $103.00 price objective on shares of Merit Medical Systems in a research note on Friday, October 31st. Wells Fargo & Company lowered their price objective on shares of Merit Medical Systems from $103.00 to $95.00 and set an “overweight” rating for the company in a research report on Friday, November 14th. Finally, Barrington Research restated an “outperform” rating and set a $106.00 target price on shares of Merit Medical Systems in a research note on Friday, November 14th. Eight investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $104.50.

Hedge Funds Weigh In On Merit Medical Systems

A number of institutional investors and hedge funds have recently bought and sold shares of MMSI. Evergreen Capital Management LLC grew its holdings in shares of Merit Medical Systems by 2.4% during the first quarter. Evergreen Capital Management LLC now owns 4,616 shares of the medical instruments supplier’s stock worth $488,000 after purchasing an additional 108 shares during the last quarter. Ameritas Investment Partners Inc. grew its holdings in Merit Medical Systems by 2.2% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 5,973 shares of the medical instruments supplier’s stock worth $558,000 after acquiring an additional 131 shares during the last quarter. MassMutual Private Wealth & Trust FSB increased its position in Merit Medical Systems by 55.6% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 375 shares of the medical instruments supplier’s stock valued at $35,000 after acquiring an additional 134 shares during the period. Norden Group LLC raised its stake in shares of Merit Medical Systems by 5.7% during the third quarter. Norden Group LLC now owns 2,536 shares of the medical instruments supplier’s stock valued at $211,000 after acquiring an additional 137 shares during the last quarter. Finally, US Bancorp DE lifted its holdings in shares of Merit Medical Systems by 3.8% during the first quarter. US Bancorp DE now owns 3,936 shares of the medical instruments supplier’s stock worth $416,000 after purchasing an additional 145 shares during the period. Institutional investors and hedge funds own 99.66% of the company’s stock.

About Merit Medical Systems

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.